(Q46565998)

23 December 2017

title

Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes (English)

1 reference

23 December 2017

1 reference

1

Mori J Krantz

1 reference

23 December 2017

author name string

Joel A Garcia

series ordinal

2

1 reference

23 December 2017

Philip S Mehler

series ordinal

3

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

23 December 2017

published in

Pharmacotherapy

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

611-614

1 reference

23 December 2017

Torsade de pointes associated with very-high-dose methadone

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Treating opioid dependence. Growing implications for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Deaths attributable to methadone vs buprenorphine in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

QT interval prolongation in patients on methadone with concomitant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Which potent opioid? Important criteria for selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Opioid dependence treatment, including buprenorphine/naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

Haemodynamic effects of buprenorphine after heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.4.611.61020

10.1592/PHCO.25.4.611.61020

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017